Meet the editor

Dr. Samy I. McFarlane, MD, MPH, MBA, FACP is a distinguished teaching professor of Medicine and Endocrinology and an Associate Dean at the College of Medicine, State University of New York-Downstate Health Science University, USA. He has extensive experience in clinical and translational research and has led the largest center in North America in the landmark

diabetes prevention trial, the DREAM trial. He has edited several books and authored over 300 publications on diabetes, hypertension, dyslipidemia, cardiovascular disease, and related areas. His work has been among the most read articles with over 10,000 citations in major medical journals. He is the Founding Editor-In-Chief for the International Journal of Clinical Research and Trials and has served as the Editor-In-Chief for several other journals. He is a nationally and internationally recognized scholar who served as a member at the National Institute of Health-NIDDK committee (two terms) and as a chair of the NIH-NIDDK U01 review committee (twice). He has received multiple recognitions including Certificate of Special Congressional Recognition and he also served as District President for the American College of Physicians. He is also a well-recognized mentor with some of his trainees serving in leadership positions at the NIH and other major institutions.

Contents

**Section 1**

**Section 2**

Guidelines

**Preface III**

Atherogenesis **1**

**Chapter 1 3**

**Chapter 2 11**

Dyslipidemia in Special Populations **43**

**Chapter 3 45**

**Chapter 4 71**

**Chapter 5 85**

Introduction to Lipid Metabolism and the Role of Dyslipidemia in

Introductory Chapter: Overview of Lipoprotein Metabolism

Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for

Dyslipidemia in Special Populations, the Elderly, Women, HIV, Chronic Kidney Disease and ESRD, and Minority Groups

*by Amarpali Brar, Jeans M. Santana, Moro O. Salifu and Clinton D. Brown*

Prevalence of Dyslipidemia and Goal Attainment with Lipid-Lowering Therapy: Insights from Thai Multicenter Study and Overview of the Major

*Rapeephon Kunjara-Na-Ayudhaya, Bandit Thinkhamrop and Piyamitr Sritara*

*by Songkwan Silaruks, Charn Sriratanasathavorn, Petch Rawdaree,* 

Postprandial Lipemia as Cardiovascular Disease Risk Factor

*by Neil Francis Amba and Leilani B. Mercado-Asis*

Treatment of Dyslipidemia Based on Recent Guidelines *by Perry Wengrofsky, Justin Lee and Amgad N. Makaryus*

*by Angelina Zhyvotovska, Denis Yusupov* 

*and Samy I. McFarlane*

## Contents


